(Press-News.org) The portion of our nervous systems responsible for the “fight or flight” response can shape the severity of potentially deadly C. difficile infections, new research from the University of Virginia School of Medicine reveals.
The findings suggest that doctors may be able to save patients from the infections – a plague for hospitals and nursing homes – by using drugs to quiet the hyperactive nervous system response, the researchers say.
“Compared to how much we know about immune system influences in C. difficile infections, the field is just scratching the surface in understanding neuronal contributions to disease,” said researcher William A. Petri Jr., MD, PhD, of UVA Health’s Division of Infectious Diseases and International Health. “Newly identifying components of the nervous system that worsen inflammation will allow us to determine potential therapeutic targets and biomarkers for patients at risk of severe disease.”
About C. Difficile
C. difficile, or C. diff as it is commonly known, is a perpetual burden for healthcare facilities. The bacterium naturally lives in our guts, but extensive antibiotic use, particularly among patients who are hospitalized or in nursing care, can allow it to establish dangerous infections. Approximately 500,000 Americans develop C. difficile infections each year, and about 30,000 die.
Further, patients who make it through the severe diarrhea, nausea, fever and colitis C. difficile can cause are not necessarily in the clear: One in six will develop another C. diff infection within eight weeks, according to the federal Centers for Disease Control and Prevention.
The new UVA research reveals the critical role the nervous system plays in severe C. difficile infections. The researchers found that the “sympathetic” nervous system – the branch that responds to dangerous situations – can be a key driver of serious C. diff.
Normally, our “fight or flight” response is helpful for avoiding danger. It helps us respond quickly, improves our eyesight, boosts our strength. It also can stimulate our immune system and help us recover from injury. But in C. difficile cases, the nervous system can have a hyperactive response that becomes part of the problem, and UVA’s new research explains why.
“Neurons are the first responders that coordinate defenses against toxic attacks. Sometimes those responders don’t recruit the right size and kind of artillery and that can make things worse,” said researcher David Tyus, a neuroscience graduate student at UVA. “Interestingly, the receptor we identified as important in C. difficile infection [the alpha 2 adrenergic receptor] has also been linked to irritable bowel syndrome. I’m curious to know if there could be a unifying underlying mechanism between the two disease contexts.”
Promisingly, the researchers found that targeting the receptor in lab mice reduced intestinal inflammation and decreased C. difficile severity and mortality. That suggests that, with further research, doctors may be able to take a similar tact to better treat severe C. diff infections in patients. For example, they may be able to surgically remove a portion of nerves in the gut, or they may be able to develop medicines to target the alpha 2 receptor – as Petri and Tyus are attempting to do.
“Our next step is to determine which cells with the alpha 2 receptor are receiving signals from the sympathetic nervous system and play a role in C. difficile-mediated disease,” Petri said. “We are very excited to think about how our findings translate to clinic and how the sympathetic nervous system might play a role in recurrent infection. I hope that this study sets the foundation for future findings of how neurons affect the course of C. difficile infection outcomes.”
Findings Published
The researchers have published their findings in the scientific journal Cell Reports Medicine. The article is open access, meaning it is free to read.
The research team consisted of Tyus, Jhansi L. Leslie, Farha Naz, Jashim Uddin, Brandon Thompson and Petri. Petri is a consultant for TechLab Inc., a company that produces diagnostic tests for C. difficile. Petri and Tyus are also seeking a patent with UVA for alpha 2 adrenergic receptor blockade for the treatment of C. difficile colitis.
The study was supported by the National Institutes of Health, grants T32AI007046, F31AI161787-04t, R01348 AI152477 and R01AI124214.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.
END
Faulty 'fight or flight' response drives deadly C. difficile infections, research reveals
2024-10-10
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Checking out the boundaries: Milestone in lipidomics achieved
2024-10-10
Results of the first phase of a Ceramide Ring Trial have just been published in the renowned journal Nature Communications, representing a significant landmark in the field of lipidomics. This achievement, involving researchers at the University of Vienna and scientific teams in Singapore, Julich and Espoo, represents a groundbreaking advance in the establishment of ceramide reference values, plasma lipids involved in such as cardiovascular diseases. The ring trial was performed under the umbrella of the International Lipidomics Society ...
SNU-KAIST researchers jointly develop a new visible light communication encryption technology using chiral nanoparticles
2024-10-10
Seoul National University(SNU) College of Engineering announced that a joint research team led by Professor Ki Tae Nam from the Department of Materials Science and Engineering at SNU and Professor Junil Choi from the Korea Advanced Institute of Science and Technology (KAIST) has developed a novel visible light communication encryption technology with high security using chiral nanoparticles.
Just as a lighthouse provides a guiding beam in the vast darkness of the sea, light-based information transmission has been a crucial means of communication throughout human history. ...
HPTN 091 study shows encouraging uptake and adherence to oral PrEP among transgender women
2024-10-10
DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) presented results from HPTN 091 (“I Am Study”) at the HIVR4P 2024 conference in Lima, Peru. The study examined the acceptability and feasibility of an integrated multicomponent strategy to enhance daily oral HIV pre-exposure prophylaxis (PrEP) uptake and adherence among transgender women in a randomized immediate versus deferred design. The integrated care strategy included the provision of gender-affirming hormone ...
Gonzalez receives award to study causes of racial disparities in amputation rates in Indiana
2024-10-10
INDIANAPOLIS --More than 8 million people, ages 40 and older, living in the U.S. are affected by peripheral arterial disease, a lifelong medical condition and the most common cause of limb amputation in the country. A data scientist, health services researcher and vascular surgeon who studies health equity, Andrew A. Gonzalez, M.D., J.D., MPH, of the Regenstrief Institute and the Indiana University School of Medicine, has received a 2024 Ralph W. and Grace M. Showalter Research Trust award to conduct a new study, Exploring Causes of Racial Disparities in Amputation Rates in Indiana.
Dr. ...
Mount Sinai opens state-of-the-art center for patients with complex conditions including Lyme disease and long COVID
2024-10-10
Mount Sinai’s Department of Rehabilitation and Human Performance has announced the grand opening of the Cohen Center for Recovery From Complex Chronic Illnesses (CoRE), providing clinical care for patients with conditions such as long Lyme disease/Lyme+, long COVID, and other infection-associated complex chronic illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Ehlers-Danlos syndrome (EDS).
Supported by philanthropy from various donors, including an inaugural gift from Beth and ...
$14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP
2024-10-10
PHILADELPHIA— A $14M grant will fund research on gene-editing therapies for rare metabolic diseases at the Perelman School of Medicine at the University of Pennsylvania (Penn) and Children’s Hospital of Philadelphia (CHOP). The research will focus specifically on developing therapies for urea cycle disorders, which impact roughly 1 in every 35,000 children. Using a form of CRISPR technology, the ultimate vision of the four-year grant is to create a platform for rapid development of personalized gene-editing therapies for ...
One experiment: The brain’s landscapers
2024-10-10
Imagine yourself sometime in the far future aboard a routine rocket to Mars. Someone just spilled their drink. Without gravity, it collects in floating blobs that ripple right before your eyes. Now freeze.
What you see might look something like the above image from Cold Spring Harbor Laboratory’s (CSHL’s) Cheadle lab. But those purple and green blobs aren’t the floating remains of somebody’s drink. They’re mysterious cells in the brain’s visual cortex called OPCs.
The visual cortex processes everything we see. Incoming visual information is ...
AI-supported dermatology: Now for darker skin tones too, thanks to a new data set
2024-10-10
In many countries in Africa, up to nine out of ten children suffer from a skin problem, and there are far too few local dermatologists. Artificial intelligence could help with diagnosis, but needs to be trained with the relevant images, so researchers have created a new data set for dark skin tones.
Demand is high, the lack of dermatologists acute: in many countries in Africa, there is less than one dermatology specialist per one million people – compared to the World Health Organization (WHO) recommendation of ...
Understanding how smiling influences relationship building during real-life conversations
2024-10-10
Smiling during conversations creates warmth, making people feel more comfortable and connected. For example, a friendly smile when meeting someone new can ease nervousness. A smile can soften tension in a debate, showing respect among the participants despite disagreement. In fact, extensive studies have been conducted in the past in an attempt to understand smiling interactions in a natural conversation. Despite these studies, however, little is known about the extent to which one’s smile influences or gets affected by the other person’s smile during a conversation.
A new study sought to investigate this by quantifying ...
British Heart Foundation Data Science Centre launches first open challenge to explore AI ECG potential
2024-10-10
The British Heart Foundation (BHF) Data Science Centre, led by Health Data Research UK, is hosting an open challenge which invites competitors to explore the potential of Artificial Intelligence to improve the use of electrocardiogram (ECG) for cardiovascular disease patient care. The challenge has been co-designed with members of public and patients affected by cardiovascular disease.
The BHF Data Science Centre is collaborating with experts from the University of Edinburgh to use a synthetic imaging dataset made up of approximately 20,000 simulated electrocardiogram (ECG) images. Competitors will be invited to develop algorithms which can make ...